CollPlant Biotechnologies Ltd CLGN

NAS: CLGN | ISIN: US19516R1077 30/04/2025

2,120 USD (-4,29%)

(-4,29%) 30/04/2025

Grafiek CollPlant Biotechnologies Ltd

Grafiek CollPlant Biotechnologies Ltd

1 dag1d -4,29%
1 week1w -4,07%
1 maand1m -17,51%
3 maanden3m -43,16%
6 maanden6m -43,32%
1 jaar1j -63,32%
5 jaar5j -80,89%

CollPlant Biotechnologies Ltd in het nieuws

Toon enkel gratis nieuws

15 april 2025 · CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies · Persbericht

26 maart 2025 · Collplant Biotechnologies Reports 2024 Financial Results And Provides A Corporate Update · Persbericht

19 maart 2025 · Collplant Biotechnologies Announces Date For 2024 Fourth Quarter And Full Year 2024 Financial Results And Conference Call Information · Persbericht

20 augustus 2024 · Collplant Biotechnologies Reports 2024 Second Quarter Financial Results And Provides Corporate Update · Persbericht

19 augustus 2024 · CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants · Persbericht

6 augustus 2024 · Collplant Biotechnologies Announces Date For 2024 Second Quarter Financial Statements And Conference Call Information · Persbericht

29 juli 2024 · CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report · Persbericht

29 mei 2024 · CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update · Persbericht

16 mei 2024 · Collplant Biotechnologies Announces Date For 2024 First Quarter Financial Results And Conference Call Information · Persbericht

4 april 2024 · Collplant Biotechnologies Reports 2023 Full Year Financial Results And Provides Corporate Update · Persbericht

Profiel CollPlant Biotechnologies Ltd

Gezondheidstechnologie

Medische Specialiteiten

Productie van chirurgische apparatuur

CEO: Yehiel Tal

Werknemers: 70

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe